3281

12th EVRS Meeting
Macular edemas. Medical vs surgical retina: new frontiers

12th EVRS Meeting
Macular edemas. Medical vs surgical retina: new frontiers

Datum
15.09.2012, 09:00 - 18.09.2012, 13:20
Kongress
Dresden
Sprache
Englisch
Gebühren ab
250.00 EUR
Veranstalter
EVRS European VitreoRetinal Society (Scientific Organization)
SARL European Vitreo Retinal Services Company (EVRSC) (Event-Organizer) Anja LEPPICH / CEO
Organisator

Congress Committee:
Didier Ducournau (Nantes, F) Permanent Congress Director
Klaus Lucke (Bremen, D) Permanent EVRTS Director
EVRS European VitreoRetinal Society
Parkallee 301
28213 Bremen
Tel.: +49 (0)421 566 5209
Fax: +49 (0)421 566 5349

The 12th Meeting of the EUROPEAN VITRORETINAL SOCIETY presents a new congress concept. The speakers ar invited to participated in "roundtable" talks to different subjects as IVT for Macula Edema, Surgery for PDR, Drops, Surgery for Macular Edema, Laser for PDR, Vitrectomy etc. The question "Medical vs Surgical Retina: What should we do" will be answerd at the end of the debates.
  • Basisinformation
    Datum
    15.09.2012, 09:00 - 18.09.2012, 13:20
    Kongress
    Dresden
    Sprache
    Englisch
    Gebühren ab
    250.00 EUR
    Veranstalter
    EVRS European VitreoRetinal Society (Scientific Organization)
    SARL European Vitreo Retinal Services Company (EVRSC) (Event-Organizer) Anja LEPPICH / CEO
    Organisator

    Congress Committee:
    Didier Ducournau (Nantes, F) Permanent Congress Director
    Klaus Lucke (Bremen, D) Permanent EVRTS Director
    EVRS European VitreoRetinal Society
    Parkallee 301
    28213 Bremen
    Tel.: +49 (0)421 566 5209
    Fax: +49 (0)421 566 5349

  • VERANSTALTUNGSORT
    Maritim Hotels Hotel & Internationales Congress Center
    Ostra-Ufer 2 / Devrientstr. 10 - 12
    01067 Dresden, DE
  • Programm

    Saturday, September 15th

     

    09:00 – 12:30 EVRTS Update (for Alumni only) Klaus Lucke and EVRTS lecturers

    14:00 – 18:00 Courses

    • High School of Ocular Trauma — When Anterior Meets Posterior, Cesare Forlini
    • Pathologic Myopia,  Silvia Bopp
    • Young EVRS — IVT, Agnieszka Nowosielska
    • Update on Macular Degeneration, Ron Adelman
    • Young EVRS — PPV, Agnieszka Nowosielska
    • Vitreo Macular Interface Disorders. Jerzy Nawrocki & Hassan Mortada

    17:30 - 19:30 Retinawas at EVRS Directed by Kourous A. Rezaei
                              A Comprehensive Video Course on Retinal Misadventures in the Operation Room

     

    Sunday, September 16th

     

    Macular Edema General Considerations

    08:00 Basic Science

    •     Neurobiological Principles Applied to Retinal Diseases, Nicolas Cuenca
    •     Pathological Findings in Macular Edema, Didier Ducournau
    •     Quantitative Determination and Comparison of Intravitreal Cytokines in PDR and RVO, Michael Koss
    •     Self Testing in Macular Edema: Possible Applications and Their Limits, Wolfgang Schrader


    09:15 Principles of Treatment

    •     27 G One Pars Plana Port Vitrectomy with a Reflow Strategy, Cesare Forlini
    •     Various Dyes forl ILM Peeling, Silvia Bopp
    •     ILM Peeling Technique, Jean-Paul Amar
    •     ILM Peeling Different Tricks, Didier Ducournau
    •     History of Development of Ranibizumab and Bevacizumab, Ron Adelman
    •     Persistent Ocular Hypertension Following Intravitreal Anti-VEGF Agents, Ron Adelman
    •     Discussion


    10:45 Idiopathic Epiretinal Membrane

    •     What is an ERM; How Could ILM Peeling Work? Didier Ducournau
    •     The Importance of Gas Injection in Idiopathic ERM Peeling Recovery, Philippe Koch
    •     Incidence of Cystoid Maclar Edema After Vitrectomy for ERM, Barbara Parolini
    •     Long-term Spectral Domain OCT After Surgery for ERM, Zosia Michalewska
    •     En-face OCT Analysis of the Retinal Surface Changes After ILM Peeling for ERM,
          Jean-François Le Rouic
    •     What Happens to the Macula Following ERM Surgery: OCT and Visual Changes, Sengul Ozdek
    •     Natural Course and Surgical Treatment of Vitreomacular Traction Syndrome, Jerzy Nawrocki
    •     The EVRS Macular Edema Study Results
    •     Discussion


    Macular Edema After Retinal Vein Occlusion
    13:50 Various Treatments

    •     3 Bevacizumab vs 2 Triamcinolone Injections in Recent CRVO, Alireza Ramezani
    •     3 Bevacizumab vs 2 Triamcinolone Injections in Recent BRVO, Alireza Ramezani
    •     Combined Therapy for Recurrent Macular Edema Following RVO, Maurizio Mete
    •     Combined Therapy of Macular Edema Following RVO, Diana Chichur
    •     Evaluating Adjunctive Surgery to Ozurdex for the Treatment Macular Edema Following RVO,
          Frank Becquet
    •     Medical Limits in Macular Edema After RVO, Guy L’Helgoual’ch
    •     Surgery Associated with Intravitreal Anti-VEGF Agents in CRVO. A More Rational Approach?,
          Giampaolo Gini
    •     ILM Peeling in RVO, Jean-Paul Amar
    •     ILM Peeling in RVO, Didier Ducournau

     

    15:40 Review of Literature &  Debate: What Should We Do?

    •     Literature & Posters Review
    •     The EVRS Macular Edema Study Results
    •     Discussion

     

    16:35 - 18:35 Retinaws at EVRS, directed by Kourous A. Rezaei:
                              When the Going Gets Tough The Tough Get Going
                              A comprehensive video course on retinal misadventures in the operating room

     

     Monday, September 17th

     
    Diabetic Macular Edema
    08:15 Fundamentals of DME

    •     Terminologic Confusion in DME, Sengul Ozdek
    •     Vitreoretinal Interface Abnormalities Associated with Diffuse DME: Diagnosis and Management, Hassan Mortada
    •     High Systolic Blood Pressure is Related to Macular Edema in Diabetic Patients, Soo Geun Joe
    •     Discussion


    09:00 ILM Peeling

    •     DME: 15 Injections or 1 Surgery?, Ferenc Kuhn
    •     Vitrectomy for DME – An Alternative to Anti-VEGF Therapy?, Andreas Schüler
    •     Vitrectomy Outcome in Traction Diffuse DME. Hassan Mortada
    •     Vitrectomy Outcome in Resistent Non-tractional Diffuse DME, Hassan Mortada
    •     PPV in Management of Type 1 Non-tractional DME After Failure of all Therapies, Ihab Saad Othman
    •     Does Vitreous Surgery for Diabetes Complications Have an Influence on the Course of Macular Edema in Long-term Follow-up?, Jerzy Nawrocki
    •      ILM Peeling in Patients with Clinically Significant DME: Long-term Outcomes, Maria Chiara Freno
    •     Discussion

     

    10:30 Intravitreal Injections

    •     The Effectiveness and Safety of Triamcinolone Injections in DME, Hanna Zajac-Pytrus
    •     Effectivity of Intravitreal Triamcinolone Injections for Diabetic Cystoid Macular Edema, Alexey Putienko
    •     Comparison of Endovitreal Triamcinolone with Betamethasone in DME, Yana Sirman
    •     Fluocinolone Acetonide Implants for the Treatment of Chronic DME, Albert Augustin
    •     Treatment of Diabetic Macular Edema with Ranibizumab, Ron Adelman
    •     Aflibercept (VEGF Trap Eye, Eylea) for Treatment of Diabetic Macular Edema, Ron Adelman
    •     Discussion


    13:35 Laser

    •     Micropulse Contiguous Grid Laser for Resistant Diffuse DME, Stephen Sinclair
    •     Micropulsed 577 nm Laser Stimulation for DME, Martin Flores-Aguilar
    •     Effectiveness of Combined Betamethasone and Laser Coagulation for DME, Yana Sirman
    •     Micropulse Laser Following Intra Vitreal Bevacizumab in Diffuse DME, Ihab Saad Othman
    •     Discussion


    14:25 Severe Cases

    •     Miniinvasive Vitrectomy as a Gold Standard for Severe PDR, Cesare Forlini
    •     Severe PDR Surgical Strategy, Malgorzata Pietras-Trzpiel


    14:45 Comparative Studies

    •     Comparative Study of Vitrectomy with ILM Peeling vs Anti-VEGF in DME, Jerzy Nawrocki
    •     Multiple Therapeutical Approaches for the Same DME Case, Horia Stanca
    •     Design of a Comparative Study Anti-VEGF vs Surgery for DME, Andreas Schüler


    15:40 Review of Literture & Debate: What Should We Do?

    •     Literature & Posters Review
    •     The EVRS Macular Edema Study Results
    •     Discussion

     

    16:30 EVRS General Assembly



    Tuesday, September 18th

     

    09:00 Finally: Medical or Surgical Treatment?

    •     Management of Rubeosis Iridis, Surgery vs Medical Treatment, Theodoros Potamitis
    •     Final Visual Acuity Post Cystoid Macular Edema: To Peel or Not To Peel, Theodoros Potamitis
    •     Individualized Treatment in Macular Edema: Focal vs Diffuse, Ivan Fiser
    •     The EVRS Macular Edema Study: General Conclusions
    •     Discussion


    10:30 Zivojnovic Award Lecture

     

    11:20 Other Macular Edemas

    •     Efficacy of Citicoline in Treatment of Diffuse Macular Edema After Successful Surgery of RRD, Ivan Levytskyy
    •     Dome-shaped Macula in Non Myopic Patients; Description and Management, Fernando Faus Guijarro
    •     Modified Vitreo Retinal Instruments for Macular Surgery on Eyes with High Myopia, Lyubomyr Lytvynchuk
    •     Focal RPE Angiographic Leaks Visualized by En-face OCT: “A New Diagnostic Technique”, Vladimir Poposki
    •     Natural Course of Disc Pit, Zosia Michalewska
    •     Treatment of Optic Pit Maculopathy with Vitrectomy and Arcuate ILM Peeling, Jerzy Nawrocki
    •     Etiology and Treatment of Serous Macular Detachment Associated with Optic Pit – Clinical Case, Claudia Bacalhau
    •     Tractional Macular Edema in Coats’ Disease After Laser, Cryo and Anti-VEGF; A 25 G MIVS Approach. Cesare Forlini
    •     Macular Edema and Exudates in the Pediatric Age Group, Ihab Saad Othman
    •     Cystoid Macular Edema in Retinitis Pigmentosa, Christine Kusserow-Napp
    •     Macular Dilemas in Retinitis Pigmentosa, Agnieszka Nowosielska
    •     Management of ME in Retinitis Pigmentosa with Topical Dorzolamide, Ihab Saad Othman
    •     Citalopram Associated with Unilateral Cystoid Macular Edema, Alexik Mikulas
    •     Discussion


    13:20 End of congress

    Deadlines
    Abstract
    01.04.2013
    Hinweis
    Application as a session moderator: 1st April 2013 (please read carefully the moderator guidelines, and send an email to ddd@club-internet.fr) Abstract submission deadline: 1st April 2013
    Posters
    01.04.2013
    Hinweis
    All topics accepted. Best poster awarded.
    Videos
    16.04.2013
    Hinweis
    8 minutes or less recommended, all topics accepted.

    Rahmenprogramm

    Saturday, September 15th 20:00 Welcome Reception at the Conference Center   Sunday, September 16th 20:00 Concert at the Frauenkirche   Monday, September 17th 20:00 Gala Dinner at the Conference Center
  • Gebühren
    Fachärzte/-innen
    Gebühren ab
    480,00 EUR
    Early Bird bis 14.03.2012
    320,00 EUR
    Ärzte/-innen in Weiterbildung
    Gebühren ab
    630,00 EUR
    Early Bird bis 14.03.2012
    430,00 EUR
    Sonstige
    Gebühren ab
    250,00 EUR
    Spouse/Guest registration: 250,00 € - Includes Welcome Reception, Concert & Gala Diner.
  • Buchung / Anmeldung

    Online-Registration: www.octc.eu/MAZZXF

     

    Hotel booking with reduced rates:

  • Zertifizierung
    Keine Zertifizierung beantragt
  • Sponsoren

Veranstaltung teilen